文献速递神经免疫认知障碍与痴呆

卵巢衰老与多发性硬化女性灰质体积及残疾相关

Ovarian aging is associated with gray matter volume and disability in women with MS.
PubMed 文献 · Neurology · 2017-12-22

基于纵向队列最长10年随访,测定多发性硬化女性与健康对照血浆抗苗勒管激素(AMH)水平,发现两组AMH相似;在多发性硬化女性中,AMH每降低10倍与基线EDSS更高、MSFC z评分更差及皮层灰质体积更低相关,纵向分析显示AMH降低与EDSS升高相关。

要点

  • AMH是多发性硬化女性卵巢衰老的标记,低AMH与更重残疾相关。
  • 该关联独立于实际年龄与疾病病程。
  • 低AMH还与皮层灰质体积减少相关,提示卵巢衰老可能参与神经退行。

核心结论

  • 作为卵巢衰老标记,较低AMH水平与多发性硬化女性更重残疾和灰质丢失相关,且独立于实际年龄和疾病病程。

研究设计与样本

  • 纵向研究队列,随访最长10年,纳入多发性硬化女性412例(平均年龄42.6岁)和健康对照180例(平均年龄44岁)。
  • 采用ELISA测定基线与第3、5、8-10年血浆AMH水平,使用混合效应logistic和线性回归模型并校正年龄、病程等协变量。

主要发现

  • 多发性硬化女性与健康对照的AMH水平相似(差异0.98倍,95%CI 0.69-1.37,p=0.87)。
  • 基线多变量模型中,AMH每降低10倍与EDSS高0.43分(95%CI 0.15-0.70,p=0.003)、MSFC z评分差0.25单位(95%CI -0.40至-0.10,p=0.0015)、皮层灰质体积低7.44 mm3(95%CI -14.6至-0.30,p=0.041)相关。
  • 纵向随机截距-随机斜率模型中,AMH每降低10倍与EDSS增加0.27(95%CI 0.11-0.43,p=0.006)相关,与总灰质体积减少5.48 mm3(95%CI 11.3-0.33,p=0.065)和皮层灰质体积减少4.55 mm3(95%CI 9.33-0.23,p=0.062)相关。
  • 基线模型校正了年龄、体重指数和疾病病程。

临床怎么用

  • 对多发性硬化女性,可关注AMH等卵巢衰老指标,低AMH或提示残疾进展与灰质丢失风险更高。
  • 解读AMH与残疾/影像关联时需考虑其独立于年龄和病程,但纵向灰质结果未达统计学显著。

局限性

  • 纵向灰质体积关联的p值分别为0.065和0.062,未达常规显著性。
  • 摘要未报告队列来源、随访脱落及混杂因素等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if ovarian aging as measured by levels of anti-Müllerian hormone (AMH) is associated with pattern of multiple sclerosis (MS) progression in women. METHODS: Women with MS and healthy controls were included from a longitudinal research cohort with up to 10 years follow-up. Plasma AMH levels were measured by ELISA for baseline and years 3, 5, and 8-10. Mixed effects logistic and linear regression models were employed, with adjustments for age, disease duration, and other covariables as appropriate. RESULTS: AMH levels were similar (0.98-fold difference, 95% confidence interval [CI] 0.69-1.37, p = 0.87) in women with MS (n = 412, mean age 42.6 years) and healthy controls (n = 180, mean age 44 years). In a multivariable model of women with MS, including adjustments for age, body mass index, and disease duration, 10-fold lower AMH level was associated with 0.43-higher Expanded Disability Status Scale (EDSS) score (95% CI 0.15-0.70, p = 0.003), 0.25-unit worse MS Functional Composite z score (95% CI -0.40 to -0.10, p = 0.0015), and 7.44 mm3 lower cortical gray matter volume (95% CI -14.6 to -0.30; p = 0.041) at baseline. In a multivariable random-intercept-random-slope model using all observations over time, 10-fold decrease in AMH was associated with a 0.27 increase in EDSS (95% CI 0.11-0.43, p = 0.006) and 5.48 mm3 (95% CI 11.3-0.33, p = 0.065) and 4.55 mm3 (95% CI 9.33-0.23, p = 0.062) decreases in total gray and cortical gray matter, respectively. CONCLUSION: As a marker of ovarian aging, lower AMH levels were associated with greater disability and gray matter loss in women with MS independent of chronological age and disease duration.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Graves JS, Henry RG, Cree BAC, et al. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2017. PMID: 29273686. doi:10.1212/WNL.0000000000004843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。